New MHRA–FDA collaboration aims to boost patient access and AI safety

Positive safety and pharmacokinetic data lay foundation for phase 2 study in 2026

New survey reveals critical gaps in access to testing and timely care

Six new treatments aim to improve patient outcomes across key areas

UPSIDE study explores early transplant therapy for rare autoimmune disease

Early-stage study reveals strong immune response and safety profile for ACI-35.030

Acella and Neuvosyn report positive results for investigational DTE therapy

GM CRDC begins trials to assess real-world effectiveness of respiratory vaccines

CHMP backs AstraZeneca and Amgen’s therapy for chronic rhinosinusitis